$TDOC

Teladoc Health, Inc. (TDOC): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Teladoc Health, Inc. (TDOC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Teladoc Health Appoints Michael Grasher as Chief Financial Officer Appointment brings seasoned financial leadership as Teladoc Health advances its strategy aimed at delivering disciplined, sustainable growth NEW YORK, August 31, 2026 — Teladoc Health, Inc. (NYSE: TDO

Original reporting
Published Aug 31, 2026, 8:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$TDOC
Neutral
medium confidence
Mentioned
$TDOC
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$TDOCNeutralLow
01

Why it matters

The appointment provides fresh insight into Teladoc's financial leadership direction.

02

Market read

Executive appointment news, modest relevance for traders monitoring Teladoc.

03

What to watch

Grasher's insurance background may shift Teladoc's risk management approach.

Relevance 6/10Novelty 7/10Timing: effective immediately

Background

SEC Form 8‑K filing reporting a senior leadership change at Teladoc Health.

Company-level read

Ticker impact

$TDOCNeutralMedium confidence
Context

Teladoc Health filed an 8‑K announcing Michael Grasher as its new CFO, effective immediately.

Expected impact

Potential modest upside if market views the hire positively, but limited immediate price move.

Evidence & confidence

Executive changes are material but typically affect stock over weeks rather than intraday.

Market effects

May signal continued focus on disciplined growth in virtual care sector.

Limited to US healthcare technology investors.

Minimal global impact beyond Teladoc's operations.

Counterpoint

CFO change could be a distraction; underlying business fundamentals remain unchanged.

Key entities

  • Teladoc Health, Inc.

    Provider of virtual care services.

  • Michael Grasher

    Newly appointed Chief Financial Officer.

Related articles

$TDOCLow

Teladoc nabs insurance veteran as new CFO

Teladoc Health appointed Michael Grasher as its new CFO, effective immediately. Grasher succeeds Mala Murthy, who left in November. He brings over 30 years of experience in insurance and financial services, most recently as CFO of IFG Companies. The move follows Teladoc's recent revenue guidance reduction, partly due to challenges in its mental health unit, BetterHelp.

$TDOCMed

Teladoc appoints insurance executive Michael Grasher as CFO

Teladoc Health named Michael Grasher as its new CFO. Grasher, with over 30 years of experience in insurance, previously served as CFO of IFG Companies. The appointment follows Teladoc's recent revenue forecast cut and challenges in its mental health unit, BetterHelp. Analyst Elizabeth Anderson views the move positively for Teladoc's leadership.

$TDOCMedAI 8/10

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.